CT colonography versus colonoscopy for the detection of advanced neoplasia

Q&A on diagnosis, screening and follow-up of colorectal neoplasia

The impressive and brisk evolution of medical science prevents many physicians from a thorough update on all the research fields. Colorectal cancer diagnosis, screening and follow-up is well known to require a multi-disciplinary approach, as it is faced by several specialties such as primary care physicians, gastroenterologists, non-gastroenterologist internists, radiologists and surgeons. To address this issue in a mutual perspective, we focused on the main points of the epidemiology, diagnosis, screening and follow-up of colorectal neoplasia by using a simple "Question & Answers" structure.

Adaptive correction of the pseudo-enhancement of CT attenuation for fecal-tagging CT colonography

In fecal-tagging CT colonography (ftCTC), positive-contrast tagging agents are used for opacifying residual bowel materials to facilitate reliable detection of colorectal lesions. However, tagging agents that have high radiodensity tend to artificially elevate the observed CT attenuation of nearby materials toward that of tagged materials on Hounsfield unit (HU) scale. We developed an image-based adaptive density-correction (ADC) method for minimizing such pseudo-enhancement effect in ftCTC data. After the correction, we can confidently assume that soft-tissue materials and air are represented by their standard CT attenuations, whereas higher CT attenuations indicate tagged materials. The ADC method was optimized by use of an anthropomorphic phantom filled partially with three concentrations of a tagging agent. The effect of ADC on ftCTC was assessed visually and quantitatively by comparison of the accuracy of computer-aided detection (CAD) without and with the use of the ADC method in two different types of clinical ftCTC databases: 20 laxative ftCTC cases with 24 polyps, and 23 reduced-preparation ftCTC cases with 28 polyps. Visual evaluation indicated that ADC minimizes the observed pseudo-enhancement effect. With ADC, the free-response receiver operating characteristic curves indicating CAD performance in polyp detection yielded normalized partial area-under-curve values of 0.91 and 0.80 for the two databases, respectively, with statistically significant improvement over conventional thresholding-based approaches (p<0.05). The results indicate that ADC is a useful method for reducing the pseudo-enhancement effect and for improving CAD performance in CTC.

Small and diminutive polyps detected at screening CT colonography: a decision analysis for referral to colonoscopy

OBJECTIVE

The objective of this study was to assess the clinical and economic impact of colonoscopic referral for small and diminutive polyps detected at CT colonography (CTC) screening.

MATERIALS AND METHODS

A decision analysis model was constructed incorporating the expected polyp distribution, advanced adenoma prevalence, colorectal cancer (CRC) risk, CTC performance, and costs related to CRC screening and treatment. The model conservatively assumed that CRC risk was independent of advanced adenoma size. The number of diminutive (< or = 5 mm), small (6-9 mm), and large (> or = 10 mm) CTC-detected polyps needed to be removed to detect one advanced adenoma or prevent one CRC over a 10-year time horizon was calculated. The cost-effectiveness of polypectomy was also assessed.

RESULTS

The estimated 10-year CRC risk for unresected diminutive, small, and large polyps was 0.08%, 0.7%, and 15.7%, respectively. The number of diminutive, small, and large polyps needed to be removed to avoid leaving behind one advanced adenoma was 562, 71, and 2.5, respectively; similarly, 2,352, 297, and 10.7 polypectomies would be needed, respectively, to prevent one CRC over 10 years. The incremental cost-effectiveness ratio of removing all diminutive and small CTC-detected polyps was $464,407 and $59,015 per life-year gained, respectively. Polypectomy for large CTC-detected polyps yielded a cost-saving of $151 per person screened.

CONCLUSION

For diminutive polyps detected at CTC screening, the very low likelihood of advanced neoplasia and the high costs associated with polypectomy argue against colonoscopic referral, whereas removal of large CTC-detected polyps is highly effective. The yield of colonoscopic referral for small polyps is relatively low, suggesting that CTC surveillance may be a reasonable management option.